Drug Name: Methotrexate Injection (Sandoz), 25 mg/ml, 2 ml vial on backorder due to delay in shipping

Date Shortage Reported: 09/18/2018

Expected Resolution of Shortage: 01/01/2020

Provinces Affected: Ontario; other provinces unconfirmed

Additional Comments:                                 

  1. Patients are frequently informed by their retail pharmacist, that all MTXsc is on backorder, which is NOT the case, and may have to ‘inform’ the pharmacist
  2. The Mayne Pharma Brand of Methotrexate 25mg/mL 2mL vial, which is interchangeable with the Sandoz brand in question, is available:  DIN 02182777
  3. Over the next 6-9mos, it is likely that all formulations may, from time to time be in ‘backorder’
  4.  Use Metoject pre-filled methotrexate.  Suggestion is to fax/ call in a new prescription just to be sure that the right product/dose will be dispensed. Also, patient will need to be informed that this is a pre-filled syringe with a different concentration of methotrexate (50mg/mL instead of 25mg/mL).

Note, that Metoject does NOT use the same API (Active Principle Ingredient), and originates in Germany, whereas API for all other brands use the same API sources.